Transcriptome changes during peanut oral immunotherapy and omalizumab treatment

Pediatr Allergy Immunol. 2022 Jan;33(1):e13682. doi: 10.1111/pai.13682. Epub 2021 Oct 31.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Allergens
  • Arachis
  • Desensitization, Immunologic
  • Humans
  • Immunotherapy
  • Omalizumab* / therapeutic use
  • Peanut Hypersensitivity* / therapy
  • Transcriptome

Substances

  • Allergens
  • Omalizumab

Associated data

  • ClinicalTrials.gov/NCT02402231
  • EudraCT/2012–005625–78